Chris Ramsborg

Chris Ramsborg has a PhD. in chemical and biological engineering from Northwestern University and a B.S. in chemical engineering from Stanford University. Chris is a fellow at the American Institute of Medical and Biological Engineering. He most recently served as the Vice President, Process Science and Technology at Bristol Myers Squibb (Formerly Juno Therapeutics) in Seattle, Washington. Prior to joining the leadership team at BMS, Dr. Ramsborg served in roles of increasing responsibility within Process Sciences at Dendreon. While there, he was responsible for commercial and clinical process development, including the development of the internal capabilities for manufacturing ancillary reagents. In addition, he was responsible for developing comparability strategies to implement new technologies in bioprocesses. Dr. Ramsborg also had several translational science roles at Merck Research Labs, where he worked to translate novel assays and technologies into decision-making tools, and ultimately companion diagnostics.

Over the course of his career, Dr. Ramsborg has consistently worked in novel therapeutic areas where technology development and implementation is required for successful product development.